| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 209-214, Copyright © 1994 by American Society for Investigative Pathology
REVIEWS |
L Braun
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912.
Although many basic questions about the relationship between HIV and HPV infection remain unresolved, epidemiological studies have consistently shown a strong association between HIV infection and the development of HPV-related squamous intraepithelial neoplasia. This work indicates that HIV infection may promote the clinical manifestation of subclinical or latent HPV infection. Recent technical advances localizing virus DNA and gene products in situ will provide new avenues for investigation, allowing us to go beyond correlations and to clarify the mechanisms of interaction between the two viruses in individual patients. With improved antiretroviral therapy and prophylaxis for HIV-associated opportunistic infection and prolonged survival of women with HIV, HPV infection and its most serious consequence, cervical cancer, are likely to assume greater significance in the clinical management of HIV-infected women throughout the world. A better understanding of the role of HIV in promoting the clinical manifestation of HPV infection will be essential to the control of this disease.
This article has been cited by other articles:
![]() |
D S Hughes, N Powell, and A N Fiander Will vaccination against human papillomavirus prevent eye disease? A review of the evidence Br. J. Ophthalmol., April 1, 2008; 92(4): 460 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Xi and N. B. Kiviat Cervical Neoplasia and Highly Active Antiretroviral Therapy J Natl Cancer Inst, July 21, 2004; 96(14): 1051 - 1053. [Full Text] [PDF] |
||||
![]() |
I. HEARD, J.-M. TASSIE, V. SCHMITZ, L. MANDELBROT, M. D. KAZATCHKINE, and G. ORTH Increased Risk of Cervical Disease Among Human Immunodeficiency Virus-Infected Women With Severe Immunosuppression and High Human Papillomavirus Load Obstet. Gynecol., September 1, 2000; 96(3): 403 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petter, K. Heim, M. Guger, A. Ciresa-Kö nig, N. Christensen, M. Sarcletti, U. Wieland, H. Pfister, R. Zangerle, and R. Höpfl Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women J. Gen. Virol., March 1, 2000; 81(3): 701 - 708. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |